Yongbo Yang

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Perioperative Safety Analysis of Preoperative Targeted Therapy in Patients 
with ALK-positive Non-small Cell Lung Cancer

Perioperative Safety Analysis of Preoperative Targeted Therapy in Patients 
with ALK-positive Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: August 24, 2026

Alcohol Consumption and Age-Specific Risk of Esophageal Cancer: Prospective Cohort Study.

Alcohol Consumption and Age-Specific Risk of Esophageal Cancer: Prospective Cohort Study.

Journal: JMIR public health and surveillance
Published: February 05, 2026

Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world cohort study.

Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world cohort study.

Journal: Journal of thoracic disease
Published: February 21, 2025

Effects of Postoperative Complications on Overall Survival Following Esophagectomy: A Meta-Analysis Using the Restricted Mean Survival Time Analysis.

Effects of Postoperative Complications on Overall Survival Following Esophagectomy: A Meta-Analysis Using the Restricted Mean Survival Time Analysis.

Journal: Thoracic cancer
Published: December 19, 2024

Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer.

Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer.

Journal: Thoracic cancer
Published: May 17, 2021

HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair.

HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair.

Journal: Thoracic cancer
Published: May 27, 2019

Survival After Induction Chemotherapy and Esophagectomy Is Not Improved by Adjuvant Chemotherapy.

Survival After Induction Chemotherapy and Esophagectomy Is Not Improved by Adjuvant Chemotherapy.

Journal: The Annals of thoracic surgery
Published: August 12, 2018

Efficacy of repeated surgery is superior to that of non-surgery for recurrent/second primary lung cancer after initial operation for primary lung cancer.

Efficacy of repeated surgery is superior to that of non-surgery for recurrent/second primary lung cancer after initial operation for primary lung cancer.

Journal: Thoracic cancer
Published: April 23, 2018

Exploration of Postoperative Follow-up Strategies for Early Staged NSCLC Patients on the Basis of Follow-up Result of 416 Stage I NSCLC Patients after Lobectomy

Exploration of Postoperative Follow-up Strategies for Early Staged NSCLC Patients on the Basis of Follow-up Result of 416 Stage I NSCLC Patients after Lobectomy

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: March 29, 2018

Analysis of Prolonged Hospitalizations (Longer than 7 days): 115 Lung Cancer 
Patients after Video Assistant Thoracic Surgery (VATS)

Analysis of Prolonged Hospitalizations (Longer than 7 days): 115 Lung Cancer 
Patients after Video Assistant Thoracic Surgery (VATS)

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: March 29, 2018

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.

Journal: Thoracic cancer
Published: February 14, 2018

Doxorubicin and Indocyanine Green Loaded Hybrid Bicelles for Fluorescence Imaging Guided Synergetic Chemo/Photothermal Therapy.

Doxorubicin and Indocyanine Green Loaded Hybrid Bicelles for Fluorescence Imaging Guided Synergetic Chemo/Photothermal Therapy.

Journal: Bioconjugate chemistry
Published: August 16, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026